BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin K, Xia X, Rui K, Wang T, Wang S. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression. Front Oncol 2020;10:610104. [PMID: 33384962 DOI: 10.3389/fonc.2020.610104] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Merhi M, Ahmad F, Taib N, Inchakalody V, Uddin S, Shablak A, Dermime S. The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update. Semin Cancer Biol 2023;89:1-17. [PMID: 36621515 DOI: 10.1016/j.semcancer.2023.01.001] [Reference Citation Analysis]
2 Eid RA, Eldeen MA, Soltan MA, Al-Shraim M, Aldehri M, Alqahtani LS, Alsharif G, Albogami S, Jafri I, Fayad E, Park MN, Bibi S, Behairy MY, Kim B, Zaki MSA. Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors. Front Genet 2022;13:1008502. [PMID: 36726716 DOI: 10.3389/fgene.2022.1008502] [Reference Citation Analysis]
3 Shasha T, Gruijs M, van Egmond M. Mechanisms of colorectal liver metastasis development. Cell Mol Life Sci 2022;79:607. [PMID: 36436127 DOI: 10.1007/s00018-022-04630-6] [Reference Citation Analysis]
4 Kavvadas E. C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression. Medical Hypotheses 2022;167:110944. [DOI: 10.1016/j.mehy.2022.110944] [Reference Citation Analysis]
5 Shan J, Han D, Shen C, Lei Q, Zhang Y. Mechanism and strategies of immunotherapy resistance in colorectal cancer. Front Immunol 2022;13:1016646. [DOI: 10.3389/fimmu.2022.1016646] [Reference Citation Analysis]
6 Al-mterin MA, Elkord E. Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets. Exploration of Targeted Anti-tumor Therapy 2022. [DOI: 10.37349/etat.2022.00097] [Reference Citation Analysis]
7 Ma L, Ma J, Teng M, Li Y. Visual Analysis of Colorectal Cancer Immunotherapy: A Bibliometric Analysis From 2012 to 2021. Front Immunol 2022;13:843106. [PMID: 35432385 DOI: 10.3389/fimmu.2022.843106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
8 Liang W, He X, Bi J, Hu T, Sun Y. Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review). Oncol Rep 2021;46:208. [PMID: 34328200 DOI: 10.3892/or.2021.8159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Dutta R, Khalil R, Mayilsamy K, Green R, Howell M, Bharadwaj S, Mohapatra SS, Mohapatra S. Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model. Front Immunol 2021;12:706133. [PMID: 34381456 DOI: 10.3389/fimmu.2021.706133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]